Skip to main content
. 2022 Feb 4;14(2):362. doi: 10.3390/pharmaceutics14020362

Table 4.

Exogenous contrast agents with PA properties in clinical trials.

Drug Type of Cancer Clinicaltrials.gov ID Current Clinical Trials References
Cetuximab-IRDye800 Pancreatic cancer NCT02736578 Phase 2 [178]
Indocyanine green Colon cancer NCT01662752 Phase 2 [180]
Methylene blue Colorectal cancer NCT01694966 Phase 3 [181]